Related Experiment Video
Updated: Jun 1, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using
David Kershenobich1, Homie A Razavi, Curtis L Cooper
1Department of Experimental Medicine, School of Medicine, General Hospital of México, Universidad Nacional Autonoma de México, México City, México.
A new model predicts a 24% decline in Hepatitis C virus (HCV) infections in the US by 2021. However, the aging infected population will increase disease burden and mortality rates, requiring targeted public health strategies.
Area of Science:
- Epidemiology
- Public Health
- Mathematical Modeling
Background:
- Hepatitis C virus (HCV) infection causes chronic liver disease with an uncertain global epidemiology.
- The impact of HCV is projected to increase significantly in the coming decade.
Purpose of the Study:
- To develop a predictive tool for future Hepatitis C virus (HCV) prevalence globally.
- To understand the relationship between key assumptions and future disease trends.
Main Methods:
- A systems approach was employed to construct a simulation model.
- Population dynamics were modeled with inflows and outflows.
- Sensitivity analysis identified key drivers of future HCV prevalence.
Main Results:
- US HCV-infected population projected to decrease by 24% (3.15M in 2005 to 2.47M in 2021).
- HCV mortality rate forecasted to rise from 2.1% to 3.1% between 2005 and 2021.
- Only 50% of infections were diagnosed, and less than 2% were treated.
Conclusions:
- A framework for evaluating global HCV-infected populations has been developed.
- The model can assess policy impacts on future HCV challenges.
- This prediction tool can inform new public health strategies.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data
